Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Waldenström macroglobulinemia: from biology to treatment.
[waldenström macroglobulinemia]
Waldenström
macroglobulinemia
(
WM
)
is
distinct
B-
cell
lymphoproliferative
disorder
primarily
characterized
by
bone
marrow
infiltration
of
lymphoplasmacytic
cells
along
with
production
of
a
serum
monoclonal
(
IgM
)
.
In
this
review
,
we
describe
the
biology
of
WM
,
the
diagnostic
evaluation
for
WM
with
a
discussion
of
other
conditions
that
are
in
the
differential
diagnosis
and
clinical
manifestations
of
the
disease
as
well
as
current
treatment
options
.
Within
the
novel
agents
discussed
are
everolimus
,
perifosine
,
enzastaurin
,
panobinostat
,
bortezomib
and
carfilzomib
,
pomalidomide
and
ibrutinib
.
Many
of
the
novel
agents
have
shown
good
responses
and
have
a
better
toxicity
profile
compared
to
traditional
chemotherapeutic
agents
,
which
makes
them
good
candidates
to
be
used
as
primary
therapies
for
WM
in
the
future
.
Diseases
Validation
Diseases presenting
"which makes them good candidates to be used as primary therapies for wm in the future"
symptom
waldenström macroglobulinemia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom